These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 10652419)

  • 21. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
    Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
    Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
    J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
    Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
    Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
    Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.
    Fujii T; Matsushima Y; Yajima M; Sugimura T; Terada M
    Jpn J Cancer Res; 1995 Jan; 86(1):28-34. PubMed ID: 7737906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
    Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
    Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
    Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
    Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papilloma virus type 16 during treatment and follow-up.
    Baay MF; Duk JM; Burger MP; de Bruijn HW; Stolz E; Herbrink P
    Eur J Clin Microbiol Infect Dis; 1999 Feb; 18(2):126-32. PubMed ID: 10219577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia.
    Tjiong MY; Zumbach K; Schegget JT; van der Vange N; Out TA; Pawlita M; Struyk L
    Viral Immunol; 2001; 14(4):415-24. PubMed ID: 11792070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
    Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
    Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.
    Nilges K; Höhn H; Pilch H; Neukirch C; Freitag K; Talbot PJ; Maeurer MJ
    J Virol; 2003 May; 77(9):5464-74. PubMed ID: 12692247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
    Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
    Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix.
    Seresini S; Origoni M; Caputo L; Lillo F; Longhi R; Vantini S; Paganoni AM; Protti MP
    Immunology; 2010 Sep; 131(1):89-98. PubMed ID: 20545782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Spector ME; Sacco AG; Bellile E; Taylor JMG; Jones T; Sun K; Brown WC; Birkeland AC; Bradford CR; Wolf GT; Prince ME; Moyer JS; Malloy K; Swiecicki P; Eisbruch A; McHugh JB; Chepeha DB; Rozek L; Worden FP
    Clin Cancer Res; 2017 Jun; 23(11):2723-2729. PubMed ID: 27872102
    [No Abstract]   [Full Text] [Related]  

  • 37. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
    Nimako M; Fiander AN; Wilkinson GW; Borysiewicz LK; Man S
    Cancer Res; 1997 Nov; 57(21):4855-61. PubMed ID: 9354449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
    Bleul C; Müller M; Frank R; Gausepohl H; Koldovsky U; Mgaya HN; Luande J; Pawlita M; ter Meulen J; Viscidi R
    J Clin Microbiol; 1991 Aug; 29(8):1579-88. PubMed ID: 1722219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B; Xue M
    Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.